Bicycle Therapeutics PLC - ESG Rating & Company Profile powered by AI
The Disclosure score covers 17 United Nations Sustainable Development Goals including: 'Affordable & Clean Energy', 'Decent Work & Economic Growth' and 'Life below Water'. Complete ESG analysis of Bicycle Therapeutics PLC are accessed by signing up for free. The assessment of Bicycle Therapeutics PLC uses data from across the internet and also from public disclosures by Bicycle Therapeutics PLC.
Bicycle Therapeutics PLC in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.9; made up of an environmental score of 8.0, social score of 8.0 and governance score of 4.8.
6.9
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 290 | Qiagen NV | 7.0 | High |
| 290 | WuXi AppTec Co Ltd | 7.0 | High |
| 294 | Bicycle Therapeutics PLC | 6.9 | High |
| 294 | Cabaletta Bio Inc | 6.9 | High |
| 294 | AnGes Inc | 6.9 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Bicycle Therapeutics PLC have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Bicycle Therapeutics PLC disclose current and historical energy intensity?
Sign up for free to unlockDoes Bicycle Therapeutics PLC report the average age of the workforce?
Sign up for free to unlockDoes Bicycle Therapeutics PLC reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Bicycle Therapeutics PLC disclose its ethnicity pay gap?
Sign up for free to unlockDoes Bicycle Therapeutics PLC disclose cybersecurity risks?
Sign up for free to unlockDoes Bicycle Therapeutics PLC offer flexible work?
Sign up for free to unlockDoes Bicycle Therapeutics PLC have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Bicycle Therapeutics PLC disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Bicycle Therapeutics PLC conduct supply chain audits?
Sign up for free to unlockDoes Bicycle Therapeutics PLC disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Bicycle Therapeutics PLC conduct 360 degree staff reviews?
Sign up for free to unlockDoes Bicycle Therapeutics PLC disclose the individual responsible for D&I?
Sign up for free to unlockDoes Bicycle Therapeutics PLC disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Bicycle Therapeutics PLC disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Bicycle Therapeutics PLC disclose water use targets?
Sign up for free to unlockDoes Bicycle Therapeutics PLC have careers partnerships with academic institutions?
Sign up for free to unlockDid Bicycle Therapeutics PLC have a product recall in the last two years?
Sign up for free to unlockDoes Bicycle Therapeutics PLC disclose incidents of discrimination?
Sign up for free to unlockDoes Bicycle Therapeutics PLC allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Bicycle Therapeutics PLC issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Bicycle Therapeutics PLC disclose parental leave metrics?
Sign up for free to unlockDoes Bicycle Therapeutics PLC disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Bicycle Therapeutics PLC disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Bicycle Therapeutics PLC disclose the pay ratio of women to men?
Sign up for free to unlockDoes Bicycle Therapeutics PLC support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Bicycle Therapeutics PLC disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Bicycle Therapeutics PLC reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Bicycle Therapeutics PLC involved in embryonic stem cell research?
Sign up for free to unlockDoes Bicycle Therapeutics PLC disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Bicycle Therapeutics PLC disclose its waste policy?
Sign up for free to unlockDoes Bicycle Therapeutics PLC report according to TCFD requirements?
Sign up for free to unlockDoes Bicycle Therapeutics PLC disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Bicycle Therapeutics PLC disclose energy use targets?
Sign up for free to unlockDoes Bicycle Therapeutics PLC disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Bicycle Therapeutics PLC have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Bicycle Therapeutics PLC
These potential risks are based on the size, segment and geographies of the company.
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The company's oncology product candidates also comprise BT5528, a BTC that is in a Phase I/II clinical trial targeting EphA2; and BT8009, which is in Phase I/II clinical trial targeting Nectin-4. In addition, it is developing THR-149, a plasma kallikrein inhibitor that completed Phase II clinical trials for the treatment of diabetic macular edema; BT7480, a Bicycle tumor-targeted immune cell agonist (TICA) targeting Nectin-4 and agonizing; BT7455, an EphA2/CD137 Bicycle TICA, which is in preclinical studies; and BT1718, a BTC that target tumors, that is in Phase I/IIa clinical trial that express Membrane Type 1 matrix metalloproteinase. Further, the company collaborates with biopharmaceutical companies and organizations to develop programs in therapeutic areas, such as anti-infective, cardiovascular, ophthalmology, and respiratory indications. It has a clinical trial and license agreement with the Cancer Research Technology Limited and Cancer Research UK; research collaboration agreements with AstraZeneca, Sanofi, Oxurion, and the Dementia Discovery Fund; and discovery collaboration and license agreement with Genentech for the discovery and development of Bicycle peptides for multiple immuno-oncology targets. Bicycle Therapeutics plc was incorporated in 2009 and is headquartered in Cambridge, the United Kingdom.